Category

News Brief

UF researchers discover new way to inhibit virus that causes COVID-19

When the virus that causes COVID-19 enters the body, it hijacks cellular proteins and suppresses the human inflammatory response, allowing the virus to spread. University of Florida researchers have discovered a novel way in the lab to fight rapidly evolving strains of coronaviruses by breaking that cycle.

Researchers Leverage AI To Identify Sepsis Within 12 Hours

Researchers at the University of Florida have created and are using a diagnostic tool that leverages artificial intelligence to identify a patient’s likelihood of developing sepsis — and how severe it will be — as soon as 12 hours after their hospital admission.

UF/IFAS Research on Crocodiles Provides Key Insights on Wildlife Aging

Scientists at the UF/IFAS Fort Lauderdale Research and Education Center (FLREC) contributed critical research over the last 40 years of American crocodiles to a global comparative study on longevity, aging and mortality in ectothermic tetrapods. The study, published in the journal Science, represents the first data compilation of its kind using 107 populations of 77 species from 98 research institutions. The study provides a comparative analysis of mortality in the wild – a missing piece of the puzzle in science until now.

UF Partners With CIA on Improving Cybersecurity

The university and the CIA have entered an agreement to study how artificial intelligence and machine learning applications (AIML) can be used to detect and deter malicious agents that infiltrate computer networks. The work will be carried out by researchers associated with UF’s Florida Institute for National Security.

CEO of UF Startup AxoGen is appointed to EyePoint Pharmaceuticals Board of Directors

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced the appointment of Karen Zaderej to its Board of Directors. Ms. Zaderej is currently the President, Chief Executive Officer and Chair of the Board at UF Startup and Accelerate graduate AxoGen, Inc., and brings more than 35 years of biopharmaceutical and medical device experience to the role.

DHS Prize Winners Announced in $195K Challenge To Counter Extreme Temperatures

The U.S. Department of Homeland Security (DHS) announced that UF startup and Accelerate resident Micro Nano Technologies, as one of their winners in the Cooling Solutions Challenge prize competition. The winners were each awarded funding, which totaled $195,000, for their innovative and creative ideas that sought climate-friendly cooling solutions to protect people in extreme heat conditions.